Member Info for maximillion69

It was in the RNS

Yes I second that
Thanks Sparky

Matml74
thanks for you response . sounds good to me I'm in Hl will they advise all this .
how many shares do you reckon we will allocated

Mr Big
could you help ?

ok never been involved in placing before arrived here just after 35p placing , could someone please explain to me how i will get my allocation of placings are we all given a quantity per share and will i be advised by my investment company .
My sng shares in ISA , i take it i will have to sell other shares to buy my placing shares ? so if anybody is fully SNG loaded in there ISA how will they buy placing shares
Max

For the MAP, regulatory approval has to be gained on a case by case basis for usage, as the purpose of the program is to enable usage of SNG001 in a situation where a doctor believes a patient would benefit from it. The MAP does not require SNG001 to have received regulatory approval, and SNG001 has not yet been approved.

Can not see why the fuss about France
When The MAP agreement covers EU and U.K.

SNG001 already available in U.K. and Eu through the MAP

No Ex
and thats when Mr_Big moves in

Parsley
How is the Sir Prof Ste Holgate appointment sitting on the PR scale

Hat off to you Ghia . Well said ! Plenty Doctors will be fully aware of Sng And availability through MAP
especially With the 9 hospitals Involved in the trials . Synairgen are making tracks !

WedME you a star on and off this board !!
I am still interested in the MAP route and how quickly this will spread around hospitals baring in mind the amount of hospitals that was on the trial . Yes a lot of paper work but surely it gets generic . Do doctors fear ,have a good idea of the outcome , for a patient when they now what underlying problems they suffer ? I read once that maybe they do

Morning Wed thanks again for your time and input , I gather your in the medical sector are colleagues talking about and investing in SNG .. have you worked on Covid wards or ICU ?

CJ that is a great invite you may have a few to put up though ! By the way where outside the UK are you for I commit

Vol , Egypt , Kuwait , S.African not in E U , how could they be getting SNG001 I still think we are short on some news

Hi Max,

Thank you for your email. That is correct, the Managed Access Program agreement with Clinigen grants access to treatment with SNG001 for hospitalised patients in the UK and the EU. As Synairgen is a listed Company, we cannot provide further information beyond what has already been communicated to the market. Synairgen is currently in discussions with regulatory agencies to establish the route to approval for SNG001 as a treatment for COVID-19 and any material updates will be communicated as and when they happen.

Kind regards,

This was a response from Consilium am i reading it right , it is available

surely the hospitals that were on the hospital trials will be looking to use SNG001 ,

Well done We’d , such a great explanation and reassurance . You’ve put the Sparkle back Cheers

Robo when youv'e finished post it through number 10 cheers

IMO it will take 5 years for Regenerons product to reach uk even with big pharms prducing , why is he mentioning that
with Government help surely Sng could be more readily available